These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11120014)

  • 41. Etiology of early renal allograft dysfunction after live donor renal transplantation.
    Morrissey PE; Gohh R; Madras PN; Shaffer D; Davis C; Conway P; Sahyoun A; Monaco AP
    Transplant Proc; 1998 Jun; 30(4):1320. PubMed ID: 9636536
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.
    Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH
    Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eleven-year experience of kidney transplantation in patients with hepatitis B and C infection.
    Sumethkul V; Jirakranont B; Jirasiritham S; Pairoj W
    Transplant Proc; 2000 Nov; 32(7):1944-5. PubMed ID: 11120012
    [No Abstract]   [Full Text] [Related]  

  • 44. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients.
    Siu CW; Chan TM; Li FK; Choy BY; Lui SL; Lo CY; Tang S; Lo WK; Lai KN
    Transplant Proc; 2000 Nov; 32(7):1932-4. PubMed ID: 11120007
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 46. Liver function tests in hepatitis C virus infected kidney transplant recipients.
    Manfro RC; Karohl C; Goncalves LF; Senger MB; Thomé FS; Prompt CA
    Transplant Proc; 1995 Apr; 27(2):1821-2. PubMed ID: 7725519
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term results and risk factors of quadruple immunosuppression in renal transplantation.
    Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B
    Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496
    [No Abstract]   [Full Text] [Related]  

  • 48. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients.
    Gentil Govantes MA; Esforzado N; Cruzado JM; González-Roncero FM; Balaña M; Saval N; Morales JM
    Transplantation; 2012 Dec; 94(11):1131-7. PubMed ID: 23104249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.
    Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D
    Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal transplantation using hepatitis B or C serology-positive donors.
    Santos AF; Busetto F; Franco R; Keitel E; Bittar AE; Garcia VD
    Transplant Proc; 1997 Dec; 29(8):3320. PubMed ID: 9414733
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
    Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
    Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
    Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract]   [Full Text] [Related]  

  • 53. Impact of co-infection by hepatitis B virus and hepatitis C virus in renal transplantation.
    Zylberberg H; Landau A; Carnot F; Driss F; Chaix ML; Bréchot C; Kreis H; Legendre C; Pol S
    Transplant Proc; 1998 Sep; 30(6):2820-2. PubMed ID: 9745581
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome.
    Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F
    Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allograft rejection and corticosteroids in acute pancreatitis following renal and cardiac transplantation.
    Hagopian EJ; Chabot JA; Oluwole SF; Benvenisty AI; Hardy MA
    Transplant Proc; 1997; 29(1-2):583. PubMed ID: 9123139
    [No Abstract]   [Full Text] [Related]  

  • 57. Nephrotoxicity-free, mycophenolate mofetil-based induction/maintenance immunosuppression in elderly recipients of renal allografts from elderly cadaveric donors.
    Theodorakis J; Schneeberger H; Illner WD; Stangl M; Zanker B; Land W
    Transplant Proc; 2000 Feb; 32(1A Suppl):9S-11S. PubMed ID: 10686311
    [No Abstract]   [Full Text] [Related]  

  • 58. Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome.
    Coll E; Crespo M; Solé M; Campistol JM; Cofàn F; Esforzado N; Ricart MJ; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2004 Mar; 36(2 Suppl):114S-116S. PubMed ID: 15041318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful therapy of chronic renal allograft failure by enhanced immunosuppression.
    Kliem V; Tiroke T; Ehlerding G; Eberhard O; Behrend M; Frei U; Koch KM; Pichlmayr R; Brunkhorst R
    Transplant Proc; 1998 Jun; 30(4):1207-9. PubMed ID: 9636490
    [No Abstract]   [Full Text] [Related]  

  • 60. Hepatitis C virus infection after renal transplantation: prevalence and course of morphologic lesions.
    Sandrini S; Chiappini R; Setti G; Carli O; Matricardi L; Puoti M; Callea F; Favret M; Maiorca R
    Transplant Proc; 1998 Aug; 30(5):2100-1. PubMed ID: 9723405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.